Jul 15,2016

Roche Diabetes Care partnered with app company mySugr

Roche Diabetes Care and Roche Diagnostics, both offshoots of Swiss pharma company F. Hoffmann-La Roche, each made a foray into connected health devices this quarter. Roche Diabetes Care partnered with app company mySugr, in which it had previously invested. Users that own Roche’s Accu-Chek Connect meter will now be able to automatically sync blood glucose data to mySugr. These users will also have access to the pro version of the mySugr app. This integrated offering will be available first in Germany and Austria, but will eventually launch in the US and other markets, according to the company. And Roche Diagnostics launched a Bluetooth-connected device for testing blood coagulation, the CoaguChek INRange system, in Europe. An older version of the device without the Bluetooth connectivity is already available in the US and in Europe.

COLLABORATION PARTNERSHIP

#connected device

#mobile app

#software

View Analyst & Ambassador Comments
Go to original news
Jul 27,2016

Physitrack Selected for the DigitalHealth.London Accelerator Programme

Physitrack, the global digital therapeutics and telehealth provider, is thrilled to announce that the company was selected as part of the first cohort for the DigitalHealth.London Accelerator programme. Physitrack: Selected to the UK's National Health Service's first Digital Health Accelerator program. DigitalHealth.London was created for digital health businesses that would benefit from better engagement with the the UK’s National Health Service and the wider health sector, in order to refine and develop products and services that meet the needs of the system.

PRODUCT

#mobile app

#software

View Analyst & Ambassador Comments
Go to original news
Aug 02,2016

WellDoc® Announces Partnership with Human API to Explore Enhanced Data Integration Capabilities for Its BlueStar® Digital Therapeutic

Digital health technology leader WellDoc today announced a collaboration with Human API, the fastest-growing health data platform, through which the two companies will explore the unique integration of type 2 diabetes patient health data within WellDoc’s BlueStar digital therapeutic.

COLLABORATION PARTNERSHIP

#product & service

#mobile app

#software

View Analyst & Ambassador Comments
Go to original news
Aug 03,2016

Digital deals: Omada,GSK-Verily, Excellus BCBS-Wellframe and more

San Francisco-based Omada Health, an online and mobile behavioral medicine company, announced today a partnership with the American Medical Association and a new customer, Utah-based Intermountain Healthcare system, which will offer Omada’s flagship diabetes prevention program (DPP), Prevent, to its patients. The initiative will combine the AMA’s efforts to raise prediabetes awareness nationally and Intermountain’s population health strategies by using Omada’s Prevent program. Doctors and care teams will be able to refer patients to, and monitor their progress through the online and app-based program.

COLLABORATION PARTNERSHIP

#institution

#software

#mobile app

View Analyst & Ambassador Comments
Go to original news
Aug 17,2016

Digital calculator provides the estimated risk for GIST recurrence

Finnish digital technology company Netmedi has developed an online calculator that significantly improves the process of evaluating the risk of GIST (Gastrointestinal Stromal Tumor) recurrence and the need for additional treatment after surgery. The calculator is based on a risk analysis model published in 2012 by HUCH Cancer Center and Aalto University and is intended to be used in cancer care and research.

PRODUCT

#software

View Analyst & Ambassador Comments
Go to original news
Aug 29,2016

Overview: Health tech startups innovating the behavioral health space

Over the last few decades, Behavioral Health (BH) in the US has faced several challenges amidst the rise of managed care. Historically burdened with financial, staffing, and stigma barriers, investment into BH resources and infrastructure has lagged compared to other forms of medical spending. Responding to this call, the last 24 months have seen an explosion in the number of behavioral health startups. Matt Schuster adn Dan Gebremedhin analyzed and categorized the landscape of companies and start-ups pioneering BH, such as Pear Therapeutics, Happify Health and Akili Interactive Labs.

#mobile app

#software

#coaching

View Analyst & Ambassador Comments
Go to original news
Sep 14,2016

Lifescan, WellDoc finalize commercial partnership for diabetes management platform

The partnership announced in March between Johnson & Johnson subsidiary LifeScan and diabetes management company WellDoc has entered a new stage with a commercial partnership agreement, the companies announced yesterday. Per the new agreement, the companies will integrate WellDoc’s FDA-cleared BlueStar diabetes management platform and mobile application with LifeScan’s OneTouch Verio Flex smartphone-connected blood glucose monitoring system. The ultimate goal is to create a combined offering that is data-driven, comprehensive, and reimbursible by payers.

COLLABORATION PARTNERSHIP

#connected device

#mobile app

#software

View Analyst & Ambassador Comments
Go to original news
Oct 13,2016

Is Digital Therapeutics the Next Big Thing in mHealth?

Also commonly known as software-as-a-drug, the industry currently consists of a few dozen startups and about $500 million in business, but Psilos Group Managing Partner Joseph Riley says the market stands to blossom to a few hundred companies and some $6 billion in business in five years.

#mobile app

#software

View Analyst & Ambassador Comments
Go to original news
Nov 14,2016

Simple Digital Technologies Can Reduce Health Care Costs

Businesses that are serious about reducing health care costs — and improving the health and well-being of their employees — should take a serious look at digital therapeutics, which have the potential to provide effective, low-cost ways to prevent and treat chronic diseases and their consequences. Digital therapeutics are technology-based solutions that have a clinical impact on disease comparable to that of a drug. They primarily use consumer-grade technology such as mobile devices, wearable sensors, big data analytics, and behavioral science and can be delivered through web browsers, apps, or in conjunction with medical devices. They can also be deployed in real time and at scale, which is critical for intervention in chronic diseases.

#mobile app

#software

#connected device

View Analyst & Ambassador Comments
Go to original news
Dec 06,2016

One Drop Announces FDA Clearance and One Drop | Premium Launch in US, UK, and EU

One Drop today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and Conformité Européene (CE) mark approval for One Drop | Chrome, a beautiful blood glucose monitoring system.

REGULATORY FDA

#mobile app

#connected device

#software

View Analyst & Ambassador Comments
Go to original news
Subscribe to SOFTWARE